Machinery Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What are the Key Projections for the CAGR of the Machinery Market From 2025 to 2034?
The market for macular degeneration treatment has rapidly expanded over the past few years. A leap from $11.05 billion in 2024 to $12.42 billion in 2025 is anticipated, reflecting a compound annual growth rate (CAGR) of 12.4%. The past years’ growth can be linked to factors such as an aging population, lifestyle upheavals, few available therapies, increasing awareness, and advancements in healthcare infrastructure.
Expectations are high for the macular degeneration treatment market, as it is poised to experience significant expansion in the coming years. The market is projected to reach $19.06 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.3%. This impressive rise over the forecast period can be attributed to a multitude of factors. These include enhancements in research, an uptick in healthcare spending, an increased frequency of incidence rates, personalized treatment strategies, and worldwide commitment to visual health. Foreseen trends for the allocation period encompass emphasis on neuroprotection and regenerative therapies, the growth of telemedicine and remote patient monitoring, personalized medicine methodologies, exploration of stem cell treatments, and patient-centered initiatives aimed at boosting awareness and education.
How Are the key drivers Contributing to the Expansion of the Market?
The macular degeneration treatment market is anticipated to expand due to the escalating prevalence of retinal disorders. These disorders, which affect the crucial tissue involved in processing visual information, can result in distorted or even a total loss of vision. For example, the American Academy of Ophthalmology has predicted that by the year 2050, about 7.32 million individuals in the United States will be diagnosed with primary open-angle glaucoma. This term refers to a set of eye disorders most prevalent among those aged 70 to 79 years (32%), women (50%), and Hispanics (50%), with the largest demographic group being Hispanic men. Consequently, the rising prevalence of retinal disorders is fuelling the advancement of the macular degeneration treatment market.
Get Your Free Sample of the Global Machinery Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
What Are the Key Industry Players Leading the Charge in the Machinery Market’s Growth?
Major companies operating in the macular degeneration treatment market include:
• Pfizer Inc._x000D_
• F. Hoffmann-La Roche Ltd._x000D_
• Allergan Inc._x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
How Are Market Trends and Shifts Impacting the Growth Trajectory of the Machinery Market?
Leading companies in the market for macular degeneration therapy are concentrating their efforts on forming biosimilars to treat age-related macular degeneration (AMD) to improve access to effective treatments. Biosimilars are bio-medical products that bear a high resemblance to an already accepted reference product, maintaining similar levels of safety, purity, or effectiveness clinically. For example, in May of 2024, Biocon Biologics Ltd from India and Samsung Bioepis Co. Ltd from South Korea, got FDA authorization for two new biosimilars, Yesafili and Opuviz. Both biosimilars obstruct the action of vascular endothelial growth factor (VEGF), the cause behind unusual blood vessel growth in the eye. This prevention aids in averting vision loss linked with conditions such as AMD and diabetic retinopathy. The FDA approved these after conducting comparative investigations demonstrating that Yesafili and Opuviz maintain efficacy and safety levels on par with Eylea. This approval process was thorough and checked the pharmacokinetics and immunogenicity of the biosimilars.
Secure Your Global Machinery Market Report Now for Fast and Efficient Delivery!
What Are the Core Segments of the Machinery Market, and How Do They Contribute to Growth?
The macular degeneration treatment market covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections, Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options
What Regions Are Influencing the Dynamics of the Machinery Market?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Elements Shape the Definition of the Machinery Market?
Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Hemodialysis And Peritoneal Dialysis Global Market Report 2024
Endoscopy Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
